newsfilter
← Latest News
GlobeNewswire·

ObsEva to Present at the H.C. Wainwright Global Investment 2022 Conference

GENEVA, Switzerland May 16, 2022 – ObsEva SA (NASDAQ:OBSV, SIX: OBSN))), a biopharmaceutical company developing and commercializing novel therapies for women's health, today announced that Company Management will provide a corporate update at the upcom